In the absence of a submission from the holder of the marketing authorisation, ceftazidime/avibactam (Zavicefta®) cannot be endorsed for use within NHS Wales for the treatment of the following infections in adults: complicated intra-abdominal Infection; complicated urinary tract infection, including pyelonephritis; hospital-acquired pneumonia, including ventilator-associated pneumonia; infections due to aerobic Gram-negative organisms in adult patients with limited treatment options. Please refer to the AWMSG position statement on the appraisal of antimicrobial medicines.

Please also refer to Pilot of new health technology evaluation process for antimicrobials.